
National Association of Testing Authorities, Australia
Scope of Accreditation
Sonic HealthPlus Pty Ltd - Sonic HealthPlus
Site
Sonic HealthPlus
Accreditation No.
18789
Site No.
20912
Date of Accreditation
19 Feb 2013
Contact
Availability
Services available to external clients
Supervision
Not Applicable
Scope of Accreditation
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Temperature |
Creatinine | ||
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at client sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
ISO/IEC 17025 (2017)
Legal
Service | Product | Determinant |
---|---|---|
Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at permanent fixed sites | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Opiates; Tetrahydrocannabinol (THC) metabolites |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
18789
Site No.
20912
Print date
11 Jun 2025